After twelve and eighteen months of AMT, 80% of patients showed hypergonadotropic hypogonadism, and, at eighteen months, the remaining 20% showed compensated hypogonadism (high LH with normal cFT levels). The gene discussed is PLOD1; the disease is Hypergonadotropic hypogonadism.